Cargando…

Should Early Use of Chemotherapy Be Avoided in the Treatment of Metastatic Prostate Cancer?

Detalles Bibliográficos
Autor principal:	Kimura, Takahiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Japan Medical Association 2021
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8826989/ https://www.ncbi.nlm.nih.gov/pubmed/35224265 http://dx.doi.org/10.31662/jmaj.2021-0207

Ejemplares similares

Metastatic hormone-sensitive prostate cancer: How should it be treated?
por: López-Campos, Fernando, et al.
Publicado: (2021)

We should avoid the term “fluid overload”
por: Vincent, Jean-Louis, et al.
Publicado: (2018)

Diagnosis and Treatment of Prostate Adenocarcinoma
por: Kimura, Shoji, et al.
Publicado: (2021)

Women with hereditary breast cancer predispositions should avoid using their smartphones, tablets, and laptops at night
por: Mortazavi, Seyed Ali Reza, et al.
Publicado: (2018)

Should the High-flow Nasal Oxygen Therapy be used or Avoided in COVID-19?
por: Zhang, Ting-Ting, et al.
Publicado: (2020)

The seven deadly sins writers of academic papers should avoid
por: Švab, Igor
Publicado: (2017)

Treatment of metastatic prostate cancer after STAMPEDE
por: Wolf, Philipp
Publicado: (2017)

When should iron supplementation in dialysis patients be avoided, minimized or withdrawn?
por: Rostoker, Guy
Publicado: (2018)

When should surgery be used to supplement systemic therapy in metastatic renal cell cancer?
por: Hardman, Morgan, et al.
Publicado: (2023)

HER2 expression should be routinely evaluated in DCIS to avoid under or overtreatment!
por: Garg, Nidhi, et al.
Publicado: (2023)

Current Trends in Chemotherapy in the Treatment of Metastatic Prostate Cancer
por: Zhao, Janice, et al.
Publicado: (2023)

Sequential Metastatic Breast Cancer Chemotherapy: Should the Median be the Message?
por: Jung, Su Yon, et al.
Publicado: (2013)

Rupture of liver metastasis in high‐volume metastatic prostate cancer patient on androgen deprivation therapy combined with upfront docetaxel chemotherapy
por: Hata, Kenichi, et al.
Publicado: (2022)

Early CT in COVID-19: Should I or Should I Not?
por: Govil, Deepak, et al.
Publicado: (2021)

Avoidable Cancer
por: Megaw, J. W. D.
Publicado: (1923)

Recent Scientific Developments in Metastatic Prostate Cancer
por: Heidegger, Isabel
Publicado: (2020)

Applying for a doctorate in nursing? Things you should avoid from getting your application rejected
por: Younas, Ahtisham, et al.
Publicado: (2020)

Treatment intensification for metastatic prostate cancer: New treatment landscapes in androgen deprivation‐based therapy
por: Turco, Fabio, et al.
Publicado: (2022)

Should Lutetium-prostate specific membrane antigen radioligand therapy for metastatic prostate cancer be used earlier in men with lymph node only metastatic prostate cancer?
por: Yaxley, William John, et al.
Publicado: (2021)

Should we avoid invasive treatment in cancer patients with pericardial tamponade?
por: Galas, F, et al.
Publicado: (2014)

Should Antidepressants be Avoided in Pregnancy?
por: Besag, Frank M. C., et al.
Publicado: (2022)

Should Detection Avoidance Be Criminalized?
por: Logan, Wayne A.
Publicado: (2023)

What Should Be Considered for Local Excision in Early Rectal Cancer?
por: Ahn, Taesung
Publicado: (2019)

How to deal with steroids use in the management of metastatic prostate cancer during pandemic
por: Baboudjian, Michael, et al.
Publicado: (2020)

WHO SHOULD RECEIVE RADIOTHERAPY IN METASTATIC HORMONE-SENSITIVE PROSTATE CANCER?
por: Bišof, Vesna
Publicado: (2019)

Non-invasive actionable biomarkers for metastatic prostate cancer
por: Luo, Jun
Publicado: (2016)

The pros and cons of uniportal VATS segmentectomy in the treatment of early-stage lung cancer: should the procedure be prioritized?
por: Sato, Masaaki
Publicado: (2023)

There is only one big risk you should avoid at all costs, and that is the risk of doing nothing
por: Daemen, J.
Publicado: (2015)

Intermittent chemotherapy in metastatic androgen-independent prostate cancer
por: Beer, T M, et al.
Publicado: (2003)

Hormonal Intensification Should Start at the Low-risk Stage in Metastatic Prostate Cancer
por: Jazayeri, Seyed Behzad, et al.
Publicado: (2022)

Prostate radiotherapy for metastatic hormone sensitive prostate cancer—myth or reality?
por: Onal, Cem
Publicado: (2019)

Even with COVID-19 neurosurgeons should still perform necessary urgent/emergent neurosurgery to avoid major permanent neurological deficits
por: Bamps, Sven, et al.
Publicado: (2020)

Debate: Albumin administration should not be avoided
por: Allison, Simon P, et al.
Publicado: (2000)

Should adjuvant chemotherapy be formally studied among patients found to have pelvic lymph node metastases following radical hysterectomy with lymphadenectomy for early-stage cervical cancer?
por: Bujnak, Alyssa C., et al.
Publicado: (2021)

Who should be offered non-radical surgery for early-stage cervical cancer?
por: Bouchard-Fortier, Geneviève, et al.
Publicado: (2015)

Role of Chemotherapy and Mechanisms of Resistance to Chemotherapy in Metastatic Castration-Resistant Prostate Cancer
por: Lohiya, Vipin, et al.
Publicado: (2016)

Ongoing Debate on the Management of Small Renal Masses: Should They Be Treated Like Low-Risk Prostate Cancers?
por: Hong, Sung Kyu
Publicado: (2013)

The earlier the better? Apalutamide for non-metastatic castration resistant prostate cancer
por: De Santis, Maria, et al.
Publicado: (2019)

New insights for drug resistance in metastatic castration-resistant prostate cancer
por: Kushwaha, Prem Prakash, et al.
Publicado: (2022)

Can biopsy be avoided in patients with clinical suspicion of prostate cancer and a negative result on multiparametric magnetic resonance imaging?
por: Baroni, Ronaldo Hueb
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_90kg1oocong3ki99gqspd3ck73